To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses here.
For more information on this topic, please visit the Real Time Learning Network
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
Topic: Confronting BA.4/BA.5: What Clinicians Can Do
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts
Monkeypox Update: New Randomized Clinical Trial on Tecovirimat for Monkeypox Treatment
Timothy Wilkin, MD
Assistant Dean for Clinical Research Compliance
Professor of Medicine, Weill Cornell Medical College
COVID-19 Situation Update
Jay Butler, MD
Deputy Director for Infectious Diseases
U.S. Centers for Disease Control and Prevention
Outpatient Therapy Update
Meg Sullivan, MD, MPH
Chief Medical Officer
Administration for Strategic Preparedness and Response
U.S. Department of Health and Human Services
Clinician-Focused Strategies to Increase Treatment & Vaccine Uptake
Elisa Choi, MD, FACP, FIDSA
Internal Medicine and Infectious Diseases Physician in Private Practice
Harvard Medical School Faculty
Chair, Board of Governors, American College of Physicians
CDC/IDSA COVID-19 Real-Time Learning Network Advisory Group Member
Valeria Cantos, MD
Assistant Professor
Division of Infectious Diseases
Emory University School of Medicine
